Two autopsies reveal Gardasil antigens entered brain, potentially triggering inflammation and death
Posted: November 30, 2012
Pharmaceutical
A postmortem analysis of two girls from different parts of the world who died after receiving injections of Merck’s human papillomavirus (HPV) vaccine Gardasil has uncovered some astonishing evidence that components of the vaccine may be capable of triggering auto-immune
New study finds black women more prone to HPV infection, cervical cancer
Posted: April 4, 2012
Pharmaceutical
A new study conducted at the University of South Carolina indicates human papillomavirus (HPV) infections tend to last longer in college-age black females than in their white peers, potentially exposing them to a higher risk of developing cervical cancer.
Gardasil safety trials relied on “guesswork,” critics say
Posted: March 29, 2012
Pharmaceutical
Merck’s Gardasil human paillomavirus (HPV) vaccine could pose a significant health threat to the public because the U.S. Food and Drug Administration (FDA) relied on guesswork when it approved the drug, says Dr. Hanan Polansky of the Center for the
Is borax responsible for Gardasil’s adverse side effects?
Posted: March 28, 2012
Pharmaceutical
When French leaders voted to halt the sale and distribution of Merck’s human papilllomavirus (HPV) vaccine in France pending the results of a risk-benefit analysis, they said a number of questions about the vaccine remained unanswered. One of those questions
Gardasil distribution stalled in France pending government-ordered study
Posted: March 21, 2012
Pharmaceutical
The distribution of Merck’s human papillomavirus (HPV) vaccine Gardasil has been halted in France, where a government-appointed group of immunologists and other researchers has been formed to determine if the benefits of the vaccine are worth the risks.
Less frequent pap testing won’t increase cervical cancer death rate, authorities say
Posted: March 19, 2012
Pharmaceutical
New guidelines established by the American Cancer Society and the U.S. Preventive Services Task Force call for an end to annual Pap smear tests, recommending instead that women be tested once every three to five years. But as opponents of
Group offers support network for girls injured by Gardasil
Posted: March 8, 2012
Pharmaceutical
Girls who believe they have been harmed by Merck’s human papillomavirus (HPV) vaccine and their families shouldn’t have to feel alone when dealing with the devastating effects many people believe the drug can have, thanks to an international outreach of
Despite risks, pediatrics group now recommends Gardasil vaccine for boys
Posted: March 1, 2012
Pharmaceutical
The American Academy of Pediatrics (AAP) is now including Gardasil® on its list of recommended vaccines for boys as well as girls, claiming the vaccine can effectively prevent the spread of the human papillomavirus (HPV), which in rare cases can
Gardasil risks, public outcry cause Gardasil mandates to lose steam
Posted: February 24, 2012
Pharmaceutical
In 2007, Virginia became the first state in the nation to mandate the Gardasil vaccine for girls entering the sixth grade. It was a reckless move by the state legislature – a $1-million effort financed by taxpayer money and fueled
Gardasil developer: risky HPV shots currently offer little to no benefit
Posted: February 21, 2012
Pharmaceutical
“The best way to prevent cervical cancer is with routine Pap screening starting at age 21 years. Vaccination cannot prevent as many cervical cancers as can Pap screening,” Dr. Diane Harper, one of the lead developers of the Merck’s Gardasil®